Foghorn Therapeutics dropped to day and moved down -4.34%
Foghorn Therapeutics doesn't seem to be at a very clear reversal point in either direction. Foghorn Therapeutics hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. It might slide down to the $4.21 level and find some buyers to give it support.